Ignite Creation Date:
2024-05-05 @ 5:36 PM
Last Modification Date:
2024-10-26 @ 9:34 AM
Study NCT ID:
NCT00493220
Status:
COMPLETED
Last Update Posted:
2011-12-02
First Post:
2007-06-26
Brief Title:
Pharmacokinetic and Safety Study of HYLENEX Recombinant-Augmented Subcutaneous Ceftriaxone Administration
Sponsor:
Baxter Healthcare Corporation
Organization:
Baxter Healthcare Corporation